| TOVX Stock | | | USD 1.28 0.02 1.59% |
Theriva Biologics financial indicator trend analysis is much more than just breaking down Theriva Biologics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Theriva Biologics is a good investment. Please check the relationship between Theriva Biologics Total Operating Expenses and its Depreciation And Amortization accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Theriva Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in real.
For more information on how to buy Theriva Stock please use our
How to Invest in Theriva Biologics guide.
Total Operating Expenses vs Depreciation And Amortization
Total Operating Expenses vs Depreciation And Amortization Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Theriva Biologics Total Operating Expenses account and
Depreciation And Amortization. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Theriva Biologics' Total Operating Expenses and Depreciation And Amortization is 0.18. Overlapping area represents the amount of variation of Total Operating Expenses that can explain the historical movement of Depreciation And Amortization in the same time period over historical financial statements of Theriva Biologics, assuming nothing else is changed. The correlation between historical values of Theriva Biologics' Total Operating Expenses and Depreciation And Amortization is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Operating Expenses of Theriva Biologics are associated (or correlated) with its Depreciation And Amortization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation And Amortization has no effect on the direction of Total Operating Expenses i.e., Theriva Biologics' Total Operating Expenses and Depreciation And Amortization go up and down completely randomly.
Correlation Coefficient | 0.18 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.
Most indicators from Theriva Biologics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Theriva Biologics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Theriva Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in real.
For more information on how to buy Theriva Stock please use our
How to Invest in Theriva Biologics guide.At this time, Theriva Biologics'
Enterprise Value Over EBITDA is fairly stable compared to the past year.
Enterprise Value Multiple is likely to rise to 0.75 in 2024, whereas
Selling General Administrative is likely to drop slightly above 7.1
M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) |
Total Operating Expenses | 14.3M | 21.6M | 21.4M | 13.9M | Cost Of Revenue | 87K | 268K | 135K | 183.7K |
Theriva Biologics fundamental ratios Correlations
Click cells to compare fundamentals
Theriva Biologics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Theriva Biologics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Theriva Stock Analysis
When running Theriva Biologics' price analysis, check to
measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to
predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.